Cyclosporins: immunosuppressive drugs with anti-HIV-1 activity.
Cyclosporin A was introduced into clinical use in the late 1970s to reduce graft rejection after organ transplantation. This drug, a cyclic undecapeptide metabolite of the fungus Tolypocladium inflatum, interferes with lymphokine biosynthesis, hence its immunosuppressive activity. Recently, it has become clear that cyclosporins are also inhibitors of HIV-1 replication. Immunosuppressive and antiviral activities are distinct functions of the cyclosporins, but both functions require an interaction of the drug with cyclophilins.